Capital International Investors Royalty Pharma PLC Transaction History
Capital International Investors
- $590 Billion
- Q3 2025
A detailed history of Capital International Investors transactions in Royalty Pharma PLC stock. As of the latest transaction made, Capital International Investors holds 27,212,694 shares of RPRX stock, worth $1.07 Billion. This represents 0.16% of its overall portfolio holdings.
Number of Shares
27,212,694
Previous 21,880,620
24.37%
Holding current value
$1.07 Billion
Previous $788 Million
21.78%
% of portfolio
0.16%
Previous 0.14%
Shares
14 transactions
Others Institutions Holding RPRX
# of Institutions
535Shares Held
303MCall Options Held
1.34MPut Options Held
252K-
Morgan Stanley New York, NY44.2MShares$1.73 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY23MShares$901 Million0.01% of portfolio
-
Baillie Gifford & CO17.4MShares$680 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$478 Million0.45% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12MShares$469 Million0.71% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...